Elimination of β-blockers in sewage treatment plants

被引:232
作者
Maurer, M. [1 ]
Escher, B. I. [1 ]
Richle, P. [1 ]
Schaffner, C. [1 ]
Alder, A. C. [1 ]
机构
[1] Swiss Fed Inst Aquat Sci & Technol Eawag, CH-8600 Dubendorf, Switzerland
关键词
wastewater treatment plant; beta-blocker; propranolol; metoprolol; sotalol; atenolol; biodegradation rate; sorption;
D O I
10.1016/j.watres.2007.01.004
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
beta-Blockers are used to treat high blood pressure as well as patients recovering from heart attacks. In several studies, they were detected in surface water, thus indicating incomplete degradability of these substances in sewage treatment plants (STPs). In this study, we determined the sorption coefficients (K-D) and degradation rates of the four beta-blockers sotalol, atenolol, metoprolol and propranolol in sludge from an STP operating with municipal wastewater. The sorption coefficients (K-D, standard deviations in brackets) were determined as 0.04(+/- 0.03S), 0.04(+/- 0.033), 0.00(+/- 0.023) and 0.32(+/- 0.058) L g(COD)(-1), and the pseudo-first-order degradation rate constants were estimated to be 0.29(+/- 0.02), 0.69(+/- 0.05), 0.58(+/- 0.05) and 0.39(+/- 0.07) L d(-1) g(COD)(-1) for sotalol, atenolol, metoprolol and propranolol, respectively. These values translate into a typical elimination in STPs (sludge concentrations of 4 g(COD) L-1 and a hydraulic retention time of 6h) of 25%, 37%, 44% and 50% for sotalol, propranolol, metoprolol and atenolol, respectively These results are also confirmed by measurements in two municipal STPs for atenolol, sotalol and propranolol. The estimated eliminations are slightly too high for metoprolol. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1614 / 1622
页数:9
相关论文
共 33 条
[1]   Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment [J].
Andreozzi, R ;
Marotta, R ;
Paxeus, N .
CHEMOSPHERE, 2003, 50 (10) :1319-1330
[2]  
[Anonymous], ARZN UMW AUSW UNT
[3]   Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom [J].
Ashton, D ;
Hilton, M ;
Thomas, KV .
SCIENCE OF THE TOTAL ENVIRONMENT, 2004, 333 (1-3) :167-184
[4]   Occurrence and fate of pharmaceutically active compounds in the environment, a case study:: Hoje River in Sweden [J].
Bendz, D ;
Paxéus, NA ;
Ginn, TR ;
Loge, FJ .
JOURNAL OF HAZARDOUS MATERIALS, 2005, 122 (03) :195-204
[5]  
BOURNE GR, 1981, PROGR DRUG METABOLIS, V6, P77
[6]   Removal of pharmaceuticals in sewage treatment plants in Italy [J].
Castiglioni, S ;
Bagnati, R ;
Fanelli, R ;
Pomati, F ;
Calamari, D ;
Zuccato, E .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (01) :357-363
[7]  
EMEA, 2006, GUID ENV RISK ASS ME
[8]   Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach [J].
Escher, Beate I. ;
Bramaz, Nadine ;
Richter, Manuela ;
Lienert, Judit .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (23) :7402-7408
[9]   In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life [J].
Escher, BI ;
Bramaz, N ;
Eggen, RIL ;
Richter, M .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2005, 39 (09) :3090-3100
[10]  
Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009